Johannesburg - Delayed Quote ZAc

Ascendis Health Limited (ASC.JO)

85.00
+1.00
+(1.19%)
At close: May 23 at 2:36:30 PM GMT+2
Loading Chart for ASC.JO
  • Previous Close 84.00
  • Open 87.00
  • Bid 85.00 x --
  • Ask 87.00 x --
  • Day's Range 85.00 - 87.00
  • 52 Week Range 63.00 - 104.00
  • Volume 9,080
  • Avg. Volume 374,094
  • Market Cap (intraday) 532.139M
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) --
  • EPS (TTM) -0.47
  • Earnings Date Mar 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 10, 2017
  • 1y Target Est --

Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa. It operates through Consumer Health, and Medical Devices segments. The company offers natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Preg, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Solal, and Vitaforce brand names. It also provides medical devices, and diagnostic laboratory equipment and consumables under the Reuterina, Pharmachem, Sinucon, Phlexy, Clonam, Surgical Innovations, RCA, and The Scientific Group brands. It also exports its products. The company serves pharmacies, private hospitals, and doctors, as well as government. Ascendis Health Limited was incorporated in 2008 and is based in Sandton, South Africa.

www.ascendishealth.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: ASC.JO

View More

Performance Overview: ASC.JO

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is All Share Index (^J203.JO) .

YTD Return

ASC.JO
15.00%
All Share Index (^J203.JO)
11.22%

1-Year Return

ASC.JO
10.39%
All Share Index (^J203.JO)
18.46%

3-Year Return

ASC.JO
10.39%
All Share Index (^J203.JO)
36.80%

5-Year Return

ASC.JO
10.39%
All Share Index (^J203.JO)
86.51%

Compare To: ASC.JO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ASC.JO

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    532.14M

  • Enterprise Value

    478.60M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.34

  • Price/Book (mrq)

    0.95

  • Enterprise Value/Revenue

    0.31

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.46%

  • Return on Assets (ttm)

    -0.11%

  • Return on Equity (ttm)

    2.78%

  • Revenue (ttm)

    734.49M

  • Net Income Avi to Common (ttm)

    18.08M

  • Diluted EPS (ttm)

    -0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.18M

  • Total Debt/Equity (mrq)

    17.19%

  • Levered Free Cash Flow (ttm)

    278.71M

Research Analysis: ASC.JO

View More

Company Insights: ASC.JO

Research Reports: ASC.JO

View More

People Also Watch